SYNAPSE Biomedical, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
10
Active:1
Completed:6
Trial Phases
1 Phases
Not Applicable:10
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
10 (100.0%)Study of TransAeris® System for Enhanced Recovery After Surgery in France
Not Applicable
Completed
- Conditions
- Ventilator-Induced Diaphragm Dysfunction
- First Posted Date
- 2022-06-03
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Synapse Biomedical
- Target Recruit Count
- 30
- Registration Number
- NCT05404477
- Locations
- 🇫🇷
CHU - Nantes, Nantes, France
Randomized Study of TransAeris® System in Cardiac Surgery Patients at Risk of Prolonged Mechanical Ventilation
Not Applicable
Active, not recruiting
- Conditions
- Ventilator Induced Diaphragm Dysfunction
- First Posted Date
- 2021-05-25
- Last Posted Date
- 2023-08-18
- Lead Sponsor
- Synapse Biomedical
- Target Recruit Count
- 40
- Registration Number
- NCT04899856
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
Randomized Study to Investigate the Safety and Performance of Diaphragm Stimulation Coupled With Mechanical Ventilation
Not Applicable
Withdrawn
- Conditions
- Diaphragm IssuesVentilator-Induced Lung InjuryTracheostomy
- First Posted Date
- 2020-07-07
- Last Posted Date
- 2020-07-07
- Lead Sponsor
- Synapse Biomedical
- Registration Number
- NCT04457427
- Locations
- 🇹🇷
Marmara Univeristy, Istanbul, Turkey
Pilot Study of TransAeris® System in Surgical Patients at Risk of Prolonged Mechanical Ventilation
Not Applicable
Completed
- Conditions
- Ventilator-Induced Diaphragm Dysfunction
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2021-04-08
- Lead Sponsor
- Synapse Biomedical
- Target Recruit Count
- 40
- Registration Number
- NCT04309123
- Locations
- 🇺🇸
University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
NeuRx Diaphram Pacing System (DPS) Use in Amyotrophic Lateral Sclerosis (ALS)
Not Applicable
Withdrawn
- Conditions
- Amyotrophic Lateral Sclerosis
- First Posted Date
- 2017-01-27
- Last Posted Date
- 2020-03-26
- Lead Sponsor
- Synapse Biomedical
- Registration Number
- NCT03034317
- Prev
- 1
- 2
- Next
News
No news found